AXQ Capital’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$139K Buy
47,625
+9,854
+26% +$34.3K 0.02% 825
2026
Q2
$132K Sell
37,771
-19,140
-34% -$61.7K 0.01% 777
2026
Q1
$164K Buy
56,911
+1,508
+3% +$5.94K 0.02% 794
2025
Q4
$225K Buy
55,403
+37,177
+204% +$166K 0.05% 533
2025
Q3
$64.7K Sell
18,226
-38,774
-68% -$140K 0.02% 538
2025
Q2
$156K Buy
+57,000
New +$118K 0.05% 485

Other funds holding SANA

AXQ Capital's SANA Position: Q3 2026 in Review

AXQ Capital increased its Sana Biotechnology (SANA) stake by 26% in Q3 2026, buying an estimated $34.3K and bringing the position to 47,625 shares worth $139K. The position accounts for 0.02% of the portfolio, ranked #825.

AXQ Capital first reported a position in SANA in Q2 2025 and has held it in 6 quarters since. The position peaked at $225K in Q4 2025. 200 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

  • AXQ Capital held 47,625 shares of Sana Biotechnology worth $139K as of Q3 2026.
  • AXQ Capital bought 9,854 Sana Biotechnology shares in Q3 2026, an estimated $34.3K.
  • Sana Biotechnology made up 0.02% of AXQ Capital's portfolio in Q3 2026, its #825 holding.
  • AXQ Capital first reported a position in Sana Biotechnology in Q2 2025 and has held it in 6 quarters since.
  • AXQ Capital's Sana Biotechnology position peaked at $225K in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.